{"nct_id":"NCT07073547","title":"A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-07-31","start_date_type":"ACTUAL","primary_completion_date":"2028-06-19","primary_completion_date_type":"ESTIMATED","completion_date":"2028-06-19","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AZN"]}